Market closedNon-fractional

Zomedica/ZOM

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Zomedica

Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments namely Diagnostic and Therapeutic Devices. It earns the majority of revenue from the therapeutics segment.

Ticker

ZOM

Sector

Healthcare

Trading on

AMEX

Industry

Health Care Equipment and Supplies

Headquarters

Ann Arbor, United States

Employees

144

Zomedica Metrics

BasicAdvanced
$145M
Market cap
-
P/E ratio
-$0.04
EPS
0.99
Beta
-
Dividend rate
$145M
0.99
11.497
10.663
0.715
1.08
-275.73%
-8.23%
-15.07%
5.472
0.61
1.23
-4.414
25.68%
88.24%
1,128.64%
-26.00%

What the Analysts think about Zomedica

Analyst Ratings

Majority rating from 1 analysts.
Buy

Zomedica Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-146.77% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$6.2M
-15.07%
Net income
-$9.1M
-59.38%
Profit margin
-146.77%
-52.17%

Zomedica Earnings Performance

No data availble
Quarterly data is not available. You can look at the annual data instead.

Earnings per share (EPS)

Company profitability
-
QuarterlyAnnual
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Zomedica stock?

Zomedica (ZOM) has a market cap of $145M as of July 06, 2024.

What is the P/E ratio for Zomedica stock?

The price to earnings (P/E) ratio for Zomedica (ZOM) stock is 0 as of July 06, 2024.

Does Zomedica stock pay dividends?

No, Zomedica (ZOM) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Zomedica dividend payment date?

Zomedica (ZOM) stock does not pay dividends to its shareholders.

What is the beta indicator for Zomedica?

Zomedica (ZOM) has a beta rating of 0.99. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Zomedica stock

Buy or sell Zomedica stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing